Search:

Login | Subscribe

Home > Companies > Akers Biosciences, Inc...

Price	Market	Sector	Market Cap
17.00p (0.00p) 0.00%	AIM	Health Care and Related Services	£18.88m

Add to company folder | Print

Related Companies

FDT	8.12p	0.00%
AMS	32.50p	-1.51%
AOR	267.50p	0.00%
AVG	64.50p	-0.77%
BNX	p
CTN	20.00p	0.00%
CUS	1.13p	-39.89%
DSY	3.12p	0.00%
DEMG	18.00p	0.00%
GTX	53.50p	0.00%
HCEG	0.55p	0.00%
IDH	291.00p	0.00%
LID	10.25p	0.00%
MDW	6.38p	-1.92%
BPRG	p
NMT	p
NIM	2.38p	0.00%
OSH	p
PKL	p
SUN	1.75p	0.00%
MLH	17.50p	0.00%
TSL	p
ZIM	p

Commentary

Developer and manufacturer of diagnostic screening and testing products

Recent Articles

Pick of AIM	28/04/2008
Real Affinity for Langbar	03/10/2005
Akers Bioscience	28/09/2005
Akers' seal of approval	28/06/2004
Akers Biosciences	14/11/2002
	28/05/2002

Recent Announcements

Notice of First Half Results	04/08/2008
ABI Licenses Lithium System	14/07/2008
ABI Signs New Distribution Ag	26/06/2008
Placing Update	12/06/2008
Additional Listing	11/06/2008
Annual Report and Accounts	04/06/2008
Option Agreement	04/06/2008
Director/PDMR Shareholding	09/04/2008
Final Results	07/04/2008
Directorate Change	03/04/2008
More

Articles from the Sector

Medicsight	14/08/2008
Earnings rise at Southern Cross	11/08/2008
New products help Genetix	07/08/2008
Assura welcomes NHS changes	06/08/2008
Southern wins loan extension	25/07/2008
Immunodiagnostic Systems	18/07/2008
Bid move at Meldex	17/07/2008
VivoMedica	16/07/2008
Synergy maintains growth	09/07/2008
Omega Diagnostics	08/07/2008
More

Financial History

Financial Year End	31/12/2003	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	USD	USD	USD	USD	USD
Turnover	1.11	1.33	4.61	1.02	5.52
Operating Profit	-2.83	-4.20	-2.21	-8.83	-1.74
Pretax Profit	-2.89	-4.42	-1.82	-10.08	-2.37
Earnings After Tax	-2.89	-4.42	-1.82	-9.59	-1.72
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-2.89	0.00	0.00	0.00	0.00
Shareholders Funds	-2.39	-2.79	3.12	-2.67	-0.44
Net Current Assets	-2.29	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	0.00	0.00
Adj Earnings Per Share	0.00	0.00	0.00	0.00	0.00
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	201 Grove Road, Thorofare, 08086
Telephone	+1 856 848 8698
Fax	+1 856 848 0269
Executives
Chairman	David Wilbraham (1.40% holding)
Chief Executive	Thomas Nicolette (3.40% holding)
Chief Financial Officer	Robert Paratore (0.10% holding)
Exec Vice Chairman	Raymond Akers (12.40% holding)
Main Shareholders
	John Harvey: 12.2% Milan Holdings: 11.2% Dolores Akers: 6.4% DMI Investments: 6.3%
Advisers
Nominated Adviser	Arbuthnot Securities
Nominated Broker	Arbuthnot Securities
Solicitors	Jones Day
Auditors	Amper, Politziner & Mattia
Registrar	Capita Registrars

Commentary
Developer and manufacturer of diagnostic screening and testing products
Company Data
Code	AKR
Sedol	USU0094410
Shares In Issue	111.067 m
Indices	Aim
Entry on AIM	22/05/2002
Interim Results	Sep
Final Results	Apr
Year End	Dec
Accounts Due	Jun
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief